{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:34:53Z","timestamp":1793313293285,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Scientific findings have shown that Epstein-Barr virus (EBV) plays a key role in the development of some tumor diseases. Therefore, this study intends to take a practical step in controlling the pathogenicity of this virus by designing an effective vaccine based on the virus Capsid  Envelope and Epstein\u2013Barr nuclear immunogen (EBNA) Proteins Epitopes. Currently, there are no effective drugs or vaccines to treat or prevent EBV infection. So, we applied a computer-based strategy to design an epitope vaccine<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We designed a powerful multi-epitope peptide vaccine against EBV using in silico analysis. The vaccine is made up of 844 amino acids derived from three different types of proteins (Envelope, Capsid, EBNA) found in two different viral strains. responses. These epitopes have a high immunogenic capacity and are not likely to cause allergies. To enhance the vaccine immunogenicity, we used rOv-ASP-1, a recombinant Onchocerca volvulus activation associated protein-1, as an adjuvant and linked it to the vaccine\u2019s N and C terminus. The physicochemical and immunological properties of the vaccine structure were evaluated. The proposed vaccine was stable, with a stability index of 33.57 and a pI of 10.10, according to bioinformatic predictions. Docking analysis revealed that the vaccine protein binds correctly with immunological receptors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results demonstrated that the multi-epitope vaccine might be potentially immunogenic and induce humoral and cellular immune responses against EBV. This vaccine can interact appropriately with immunological receptors Also, it has a high-quality structure and suitable characteristics such as high stability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1115345","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:55:01Z","timestamp":1678755301000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Design of a multi-epitopic vaccine against Epstein-Barr virus via computer-based methods"],"prefix":"10.3389","volume":"14","author":[{"given":"Amirhossein","family":"Larijani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Kia-Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davoud","family":"Roostaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"B1","author":"Brooks","year":""},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.014.10190","article-title":"Epstein-Barr Virus and burkitt lymphoma","volume":"33","author":"Rowe","year":"2014","journal-title":"Chin J Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdsr.2017.01.002","article-title":"Epstein\u2013Barr Virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity","volume":"53","author":"Kikuchi","year":"2017","journal-title":"Japanese Dental Sci Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00382-17","article-title":"Asymptomatic primary infection with Epstein-Barr virus: Observations on young adult cases","volume":"91","author":"Abbott","year":"2017","journal-title":"J Virol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41598-018-37070-z","article-title":"Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein\u2013Barr virus (EBV)","volume":"9","author":"Ali","year":"2019","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11604-008-0291-2","article-title":"Spectrum of Epstein-Barr virus-related diseases: A pictorial review","volume":"27","author":"Maeda","year":"2009","journal-title":"Jpn J Radiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00104","article-title":"Progress in EBV vaccines","volume":"9","author":"Van Zyl","year":"2019","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2009.12.001","article-title":"Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity","volume":"12","author":"Rowe","year":"2010","journal-title":"Microbes Infect"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/BF00328978","article-title":"The ideal vaccine","volume":"7","author":"Ada","year":"1991","journal-title":"World J Microbiol Biotechnol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: Prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn201","article-title":"NCBI BLAST: A better web interface","volume":"36","author":"Johnson","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: A server for prediction of protective immunogens, tumour immunogens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12038-007-0004-5","article-title":"A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes","volume":"32","author":"Bhasin","year":"2007","journal-title":"J Biosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-118-9_14","article-title":"Application of machine learning techniques in predicting MHC binders","volume":"409","author":"Lata","year":"2007","journal-title":"Methods Mol Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.893","article-title":"Predicting linear b-cell epitopes using string kernels","volume":"21","author":"El-Manzalawy","year":"2008","journal-title":"J Mol Recognit"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","article-title":"AllerTOP - a server for in silico prediction of allergens","volume":"14","author":"Dimitrov","year":"2013","journal-title":"BMC Bioinf"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0800531","article-title":"Recombinant ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth onchocerca volvulus, can directly bind and activate immunogen-presenting cells","volume":"182","author":"He","year":"2009","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(96)66034-0","article-title":"GOR method for predicting protein secondary structure from amino acid sequence","volume":"266","author":"Garnier","year":"1996","journal-title":"Methods Enzymol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: The proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh468","article-title":"Protein structure prediction and analysis using the robetta server","volume":"32","author":"Kim","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks493","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"Ko","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: A program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J Appl Crystallography"},{"key":"B24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: A new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037019","article-title":"The adjuvanticity of an o. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9767-0","article-title":"Insertion of the designed helical linker led to increased expression of tf-based fusion proteins","volume":"26","author":"Amet","year":"2009","journal-title":"Pharm Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/15.11.871","article-title":"An analysis of protein domain linkers: Their classification and role in protein folding","volume":"15","author":"George","year":"2002","journal-title":"Protein Eng"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.3.1413","article-title":"Local interactions in protein folding: Lessons from the alpha-helix","volume":"272","author":"Aurora","year":"1997","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: Property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv Drug Delivery Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01475","article-title":"Vaccination with a paramyosin-based multi-epitope vaccine elicits significant protective immunity against trichinella spiralis infection in mice","volume":"8","author":"Gu","year":"2017","journal-title":"Front Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"151955","DOI":"10.1016\/j.imbio.2020.151955","article-title":"Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS coronavirus-2 (SARS-CoV-2)","volume":"225","author":"Sarkar","year":"2020","journal-title":"Immunobiology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.031","article-title":"An ingenious design for peptide vaccines","volume":"23","author":"Yano","year":"2005","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1159\/000445059","article-title":"Design and evaluation of a multi-epitope peptide of human metapneumovirus","volume":"58","author":"Li","year":"2015","journal-title":"Intervirology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1080\/07391102.2020.1850357","article-title":"Design of a multi-epitope-based vaccine targeting m-protein of SARS-CoV2: An immunoinformatics approach","author":"Ayyagari","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"B36","unstructured":"Uniport"},{"key":"B37","unstructured":""}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1115345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:55:03Z","timestamp":1678755303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1115345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2023.1115345"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1115345","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"article-number":"1115345"}}